Weighted Logrank Testing Procedures for the Simple Tree Alternatives

Weighted logrank testing procedures for comparing r treatments with a control when some of the data are randomly censored are discussed. Four kinds of test statistics for the simple tree alternatives are considered. The weighted logrank statistics based on pairwise ranking scheme is proposed and the covariances of the test statistics are explicitly obtained. This class of test statistics can be viewed as the general statistics of constructing the test procedures for various order restricted alternatives by modifying weights. Four kinds of weighted logrank tests are illustrated with an example. Simulation studies are performed to compare the sizes and the powers of the considered tests with the other.     

Procedures for comparing samples with multiple endpoints

Five procedures are considered for the comparison of two or more multivariate samples. These procedures include a newly proposed nonparametric rank-sum test and a generalized least squares test. Also considered are the following tests: ordinary least squares, Hotelling's T2, and a Bonferroni per-experiment error-rate approach. Applications are envisaged in which each variable represents a qualitatively different measure of response to treatment. The null hypothesis of no treatment difference is tested with power directed towards alternatives in which at least one treatment is uniformly better than the others. In all simulations the nonparametric procedure provided relatively good power and accurate control over the size of the test, and is recommended for general use. Alternatively, the generalized least squares procedure may also be useful with normally distributed data in moderate or large samples. A convenient expression for this procedure is obtained and its asymptotic relative efficiency with respect to the ordinary least squares test is evaluated.     

Improved Logrank-Type Tests for Survival Data Using Adaptive Weights

Summary .  For testing for treatment effects with time-to-event data, the logrank test is the most popular choice and has some optimality properties under proportional hazards alternatives. It may also be combined with other tests when a range of nonproportional alternatives are entertained. We introduce some versatile tests that use adaptively weighted logrank statistics. The adaptive weights utilize the hazard ratio obtained by fitting the model of Yang and Prentice (2005,  Biometrika   92 , 1–17). Extensive numerical studies have been performed under proportional and nonproportional alternatives, with a wide range of hazard ratios patterns. These studies show that these new tests typically improve the tests they are designed to modify. In particular, the adaptively weighted logrank test maintains optimality at the proportional alternatives, while improving the power over a wide range of nonproportional alternatives. The new tests are illustrated in several real data examples.     

Distribution-free Partially Sequential Tests for Treatments Versus Control Setting

In this paper we propose a class of distribution-free tests for the treatments versus control setting using the partially sequential sampling technique. Expressions for the asymptotic distributions and power for the tests are provided and criteria for adapting a particular test to have asymptotic power restrictions against alternatives of interest are discussed. Comparative results of a Monte Carlo power study are also presented.     

Properties of Statistical Tests of Neutrality for DNA Polymorphism Data

A class of statistical tests based on molecular polymorphism data is studied to determine size and power properties. The class includes TAJIMA''s D statistic as well as the D* and F* tests proposed by FU and LI. A new method of constructing critical values for these tests is described. Simulations indicate that TAJIMA''s test is generally most powerful against the alternative hypotheses of selective sweep, population bottleneck, and population subdivision, among tests within this class. However, even TAJIMA''s test can detect a selective sweep or bottleneck only if it has occurred within a specific interval of time in the recent past or population subdivision only when it has persisted for a very long time. For greatest power against the particular alternatives studied here, it is better to sequence more alleles than more sites.     

Exact and Asymptotic Power Determination For Dose‐Response Studies With Ordinal Response

In this article, we describe a conditional score test for detecting a monotone dose‐response relationship with ordinal response data. We consider three different versions of this test: asymptotic, conditional exact, and mid‐P conditional score test. Exact and asymptotic power formulae based on these tests will be studied. Asymptotic sample size formulae based on the asymptotic conditional score test will be derived. The proposed formulae are applied to a vaccination study and a developmental toxicity study for illustrative purposes. Actual significance level and exact power properties of these tests are compared in a small empirical study. The mid‐P conditional score test is observed to be the most powerful test with actual significance level close to the pre‐specified nominal level.     

UMPU and Alternative Tests for Association in 2 × 2 Tables

The use of the uniformly most powerful among the unbiased (UMPU) test was recently suggested for the study of gametic association between two polymorphic loci as an alternative to the Fisher's exact test (Zapata and Alvarez, 1997, Annals of Human Genetics 61, 71-77). However, the proposed test is not UMPU for two-sided alternatives. In this study, we present the UMPU test, discuss criticisms against the use of randomized tests, and compare the power of several tests. We show that, in many practical cases, the use of the UMPU test is less than desirable and propose the alternative adjusted-more extreme tables (A-MET) and the equal-tails (ET) tests. We suggest that some of the general arguments against the use of randomized tests can be alleviated by a newly proposed extended p-value definition.     

A linear rank test for use when the main interest is in differences in cure rates

For diseases with a positive probability of being cured, a family of alternatives to the null hypothesis of equality of survival distributions is introduced, which is designed to focus power against alternatives with differences in cure rates. The optimal linear rank test for this alternative is derived, and found to be substantially more efficient than the log-rank test for this alternative when cure rates are less than 50%, while there is little difference between the tests if the cure rates are 50% or greater. The simple test based on the difference of Kaplan-Meier estimates of the proportion cured is also examined, and found to be fully efficient for this alternative with no censoring, while its efficiency rapidly drops as censoring is increased. The new test is not a pure test of equality of cure rates when the data are censored, but rather is a test of equality of survival distributions that focuses power against late differences in the survival curves.     

Power calculations for a general class of tests of linkage and association that use nuclear families with affected and unaffected sibs

Family-based tests of association are now often used when trying to fine-map a disease susceptibility locus. Recently, several tests of linkage and association have been proposed that use nuclear families with multiple affected and unaffected sibs rather than just case-parent triads. In this paper we propose a test that generalizes these previous tests. Formulae are derived to calculate the power of the test for a randomly mating population. These power calculations are used to determine conditions under which it is advantageous to include unaffected sibs in the analysis.     

Testing hypotheses about interclass correlations from familial data

Testing problems concerning interclass correlations from familial data are considered in the case where the number of siblings varies among families. Under the assumption of multivariate normality, two test procedures are proposed for testing the hypothesis that an interclass correlation is equal to a specified value. To compare the properties of the tests, including a likelihood ratio test, Monte Carlo experiments are performed. Several test statistics are derived for testing whether two variables about a parent and child are uncorrelated. The proposed tests are compared with previous test procedures, using Monte Carlo simulation. A general procedure for finding confidence intervals for interclass correlations is also derived.     

On the Comparison of Umbrella Pattern Treatment Means with a Control Mean

This paper is concerned with comparing several increasing dose levels (treatments) with a zero dose control when the prior information about the umbrella pattern treatment means is available. The problem of testing whether there is at least one treatment which is better than the control is considered. Multiple test procedures are then proposed for deciding treatments (if any) which are better than the control. Some approximate criticial values of the proposed tests are reported. The results of a Monte Carlo power study are presented.     

Distribution-free simultaneous tests for location–scale and Lehmann alternative in two-sample problem

The paper deals with the classical two-sample testing problem for the equality of two populations, one of the most fundamental problems in biomedical experiments and case–control studies. The most familiar alternatives are the difference in location parameters or the difference in scale parameters or in both the parameters of the population density. All the tests designed for classical location or scale or location–scale alternatives assume that there is no change in the shape of the distribution. Some authors also consider the Lehmann-type alternative that addresses the change in shape. Two-sample tests under Lehmann alternative assume that the location and scale parameters are invariant. In real life, when a shift in the distribution occurs, one or more of the location, scale, and shape parameters may change simultaneously. We refer to change of one or more of the three parameters as a versatile alternative. Noting the dearth of literature for the equality two populations against such versatile alternative, we introduce two distribution-free tests based on the Euclidean and Mahalanobis distance. We obtain the asymptotic distributions of the two test statistics and study asymptotic power. We also discuss approximating p-values of the proposed tests in real applications with small samples. We compare the power performance of the two tests with several popular existing distribution-free tests against various fixed alternatives using Monte Carlo. We provide two illustrations based on biomedical experiments. Unlike existing tests which are suitable only in certain situations, proposed tests offer very good power in almost all types of shifts.     

Rank-based tests for dose finding in nonmonotonic dose-response settings

Lim and Wolfe (1997, Biometrics 53, 410-418) proposed rank-based multiple test procedures for identifying the dose levels that are more effective than the zero-dose control in randomized complete block designs when it can be assumed that the efficacy of the increasing dose levels is monotonically increasing up to a point, followed by a monotonic decrease. Modifications of the Lim-Wolfe tests are suggested that provide more practical and powerful alternatives. Two numerical examples are illustrated and the results of a Monte Carlo power study are presented.     

A Locally Most Powerful Test for Detecting a Treatment Effect in the Presence of Nonresponders

A problem that frequently occurs in many biological experiments is when some subjects in the treatment group may be unaffected by the treatment. For this reason, the distribution of responses in the treatment group is expressed as a two-component mixture, where Lehmann alternatives are used to relate the distributions of affected and unaffected patients. A distribution-free approach is proposed for testing the hypothesis of no treatment effect against the alternative that a subset of the treated subjects respond to the treatment. The test is locally optimal and structured on the basis of the empirical distribution of the untreated subjects. The properties of the test are discussed and the power function is derived. It is shown that the power increases with the proportion of responders in the experiment.     

Optimal tests shrinking both means and variances applicable to microarray data analysis

As a consequence of the "large p small n" characteristic for microarray data, hypothesis tests based on individual genes often result in low average power. There are several proposed tests that attempt to improve power. Among these, the FS test that was developed using the concept of James-Stein shrinkage to estimate the variances showed a striking average power improvement. In this paper, we establish a framework in which we model the key parameters with a distribution to find an optimal Bayes test which we call the MAP test (where MAP stands for Maximum Average Power). Under this framework, the FS test can be derived as an empirical Bayes test approximating the MAP test corresponding to modeling the variances. By modeling both the means and the variances with a distribution, a MAP statistic is derived which is optimal in terms of average power but is computationally intensive. An empirical Bayes test called the FSS test is derived as an approximation to the MAP tests and can be computed instantaneously. The FSS statistic shrinks both the means and the variances and has numerically identical average power to the MAP tests. Much numerical evidence is presented in this paper that shows that the proposed test performs uniformly better in average power than the other tests in the literature, including the classical F test, the FS test, the test of Wright and Simon, the moderated t-test, SAM, Efron's t test, the B-statistic and Storey's optimal discovery procedure. A theory is established which indicates that the proposed test is optimal in power when controlling the false discovery rate (FDR).     

The efficiency of a weighed log-rank test under a percent error misspecification model for the log hazard ratio.

For comparison of two survival distributions, it is natural to use a weighted log-rank test with weight function given by the log hazard ratio function that is anticipated a priori. This paper investigates the efficiency of this test when the a priori estimate of the log hazard ratio is subject to a specified percentage error. The test is shown to be the maximum efficiency robust test over the class of alternatives in question and a simple expression for the maximum efficiency is established.     

Optimal tests for rare variant effects in sequencing association studies

With development of massively parallel sequencing technologies, there is a substantial need for developing powerful rare variant association tests. Common approaches include burden and non-burden tests. Burden tests assume all rare variants in the target region have effects on the phenotype in the same direction and of similar magnitude. The recently proposed sequence kernel association test (SKAT) (Wu, M. C., and others, 2011. Rare-variant association testing for sequencing data with the SKAT. The American Journal of Human Genetics 89, 82-93], an extension of the C-alpha test (Neale, B. M., and others, 2011. Testing for an unusual distribution of rare variants. PLoS Genetics 7, 161-165], provides a robust test that is particularly powerful in the presence of protective and deleterious variants and null variants, but is less powerful than burden tests when a large number of variants in a region are causal and in the same direction. As the underlying biological mechanisms are unknown in practice and vary from one gene to another across the genome, it is of substantial practical interest to develop a test that is optimal for both scenarios. In this paper, we propose a class of tests that include burden tests and SKAT as special cases, and derive an optimal test within this class that maximizes power. We show that this optimal test outperforms burden tests and SKAT in a wide range of scenarios. The results are illustrated using simulation studies and triglyceride data from the Dallas Heart Study. In addition, we have derived sample size/power calculation formula for SKAT with a new family of kernels to facilitate designing new sequence association studies.     

The comparison of the confidence regions in phylogeny

In this paper, several different procedures for constructing confidence regions for the true evolutionary tree are evaluated both in terms of coverage and size without considering model misspecification. The regions are constructed on the basis of tests of hypothesis using six existing tests: Shimodaira Hasegawa (SH), SOWH, star form of SOWH (SSOWH), approximately unbiased (AU), likelihood weight (LW), generalized least squares, plus two new tests proposed in this paper: single distribution nonparametric bootstrap (SDNB) and single distribution parametric bootstrap (SDPB). The procedures are evaluated on simulated trees both with small and large number of taxa. Overall, the SH, SSOWH, AU, and LW tests led to regions with higher coverage than the nominal level at the price of including large numbers of trees. Under the specified model, the SOWH test gives accurate coverage and relatively small regions. The SDNB and SDPB tests led to the small regions with occasional undercoverage. These two procedures have a substantial computational advantage over the SOWH test. Finally, the cutoff levels for the SDNB test are shown to be more variable than those for the SDPB test.     

Nonparametric estimation and testing in a cure model.

Nonparametric generalized maximum likelihood product limit point estimators and confidence intervals are given for a cure model with random censorship. One-, two-, and K-sample likelihood ratio tests for inference on the cure rates are developed. In the two-sample case its power is compared to the power of several alternatives, including the log-rank and Gray and Tsiatis (1989, Biometrics 45, 899-904) tests. Implications for the use of the likelihood ratio test in a clinical trial designed to compare cure rates are discussed.